Chiale, Carolina
Marchese, Anthony M.
Furuya, Yoichi
Robek, Michael D. http://orcid.org/0000-0002-0709-4201
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI124006)
Article History
Received: 22 November 2020
Accepted: 22 October 2021
First Online: 22 November 2021
Competing interests
: M.D.R. reports financial relationships with CaroGen Corporation, which is seeking to commercialize the VLV platform, and research funding from Gilead Sciences, outside of this work. In addition, M.D.R. has received royalties from a patent related to the VLV technology. The other authors declare no competing interests. These entities played no role in the study design, interpretation of data, writing the manuscript, or decision to publish.